These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fluidity and fatty acid components of erythrocyte membranes in diabetic retinopathy. Yang G, Qiu H, Wang S, Deng H, Zhang S, Li L. Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):407-12. PubMed ID: 10862451 [Abstract] [Full Text] [Related]
5. Erythrocyte insulin receptors in non-insulin-dependent diabetics before and after treatment. Tanggo Y. Hiroshima J Med Sci; 1985 Sep; 34(3):331-45. PubMed ID: 3905718 [No Abstract] [Full Text] [Related]
6. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients. Rizkalla SW, Elgrably F, Tchobroutsky G, Slama G. Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670 [Abstract] [Full Text] [Related]
8. [Changes in lymphocyte and erythrocyte membrane microviscosity in cancer patients]. Goroshinskaia IA, Golotina LIu, Gorlo EI, Rovda TA, Bordiushkov IuN. Vopr Med Khim; 1999 Aug; 45(1):53-7. PubMed ID: 10205829 [Abstract] [Full Text] [Related]
9. Electron spin resonance study of the erythrocyte membrane fluidity changes in diabetes. Preoteasa EA, Ionescu-Tîrgovişte C, Grecu VV, Georgescu R. Rom J Intern Med; 1993 Aug; 31(4):271-82. PubMed ID: 8148779 [Abstract] [Full Text] [Related]
12. Possible role for insulin receptors in the mechanism of thiazide induced glucose tolerance. Gill JS, Al-Hussary N, Atkins TW, Taylor KG, Beevers DG. J Hypertens Suppl; 1984 Dec; 2(3):S573-6. PubMed ID: 6599719 [Abstract] [Full Text] [Related]
13. Erythrocyte individual phospholipids and erythrocyte membrane fluidity in subjects with vascular atherosclerotic disease with and without diabetes mellitus of type 2. Caimi G, Serra A, Catania A, D'Asaro S, Montana M, Lo Presti R, Sarno A. Microcirc Endothelium Lymphatics; 1990 Dec; 6(2-3):149-57. PubMed ID: 2247023 [Abstract] [Full Text] [Related]